Zhang, Yichi
Cai, Tianrun
Yu, Sheng
Cho, Kelly
Hong, Chuan
Sun, Jiehuan
Huang, Jie
Ho, Yuk-Lam https://orcid.org/0000-0003-3305-3830
Ananthakrishnan, Ashwin N.
Xia, Zongqi https://orcid.org/0000-0003-1500-2589
Shaw, Stanley Y.
Gainer, Vivian
Castro, Victor
Link, Nicholas
Honerlaw, Jacqueline
Huang, Sicong
Gagnon, David
Karlson, Elizabeth W.
Plenge, Robert M.
Szolovits, Peter
Savova, Guergana
Churchill, Susanne
O’Donnell, Christopher
Murphy, Shawn N.
Gaziano, J. Michael
Kohane, Isaac
Cai, Tianxi
Liao, Katherine P. https://orcid.org/0000-0002-4797-3200
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P30 AR072577, U54 LM008748, P30 AR 072577, P30 AR 072577, P30 AR 072577, U54 LM008748, U54 LM008748, NINDS098023, U54 LM008748, U54 LM008748, R01 HG009174, R01 HG009174, U54 LM008748, T32 AR007530, U54 LM008748, U54 LM008748, U54 LM008748, U54 LM008748, U54 LM008748, R01 HG009174, U54 LM008748, U54 LM008748, U54 LM008748, P30 AR 072577)
Harold and DuVal Bowen Fund
Office of Research and Development (I01-CX001025, I01-CX001025, I01-CX001025, I01-CX001025, I01-CX001025, I01-CX001025)
Pfizer
Article History
Received: 19 October 2018
Accepted: 22 July 2019
First Online: 20 November 2019
Competing interests
: R.M.P. is employed at Celgene; however, his contributions to the protocol were performed while at Brigham and Women’s Hospital. The remaining authors declare no competing interests.